A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

Figure 4

Principal component analysis. A comparison of gene expression levels in low- and high-risk populations, as determined by the expression of all examined genes (a), necroptosis-related genes (b), and lncRNAs (c) and the 7 lncRNAs of the prognostic signature (d).

(a)

(b)

(c)

(d)